You are here Home Guidance and resources Resources International scientific guidelines adopted in Australia International scientific guideline: ICH topic S1C (R2) - Note for guidance on dose selection for carcinogenicity studies of pharmaceutical EMEA/CHMP/ICH/383/1995 adopted by the Therapeutic Goods Administration (TGA) Listen Print Share LinkedIn (Twitter) Facebook Email Loading... About this guideline Overseas effective date: 23 Oct 2008 Categories: Nonclinical | Toxicology | Carcinogenicity Access this international scientific guideline For more information see International scientific guidelines adopted in Australia. Where EU guidelines adopted in Australia include references to EU legislation (including EC Directives and Regulations), the requirements contained in the referenced EU legislation are not applicable to the evaluation of medicines by the TGA.